🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent chr...
Status
Recruiting
Location
AZ Jan Palfijn
Start Date
2022-05-01
Trial ID
NCT05309863
Treatments Being Tested
The goal of this clinical trial is to evaluate whether the LasaiON program,...
Status
Not Yet Recruiting
Location
Euskal Herriko Unibertsitatea
Start Date
2026-03-30
Trial ID
NCT07498881
Treatments Being Tested
This prospective, randomized, double-blind clinical trial (with both partic...
Status
Completed
Location
faculty of physical therapy, Cairo University
Start Date
2024-10-01
Trial ID
NCT07008157
Treatments Being Tested
Tinnitus is one of the most prevalent symptoms that causes more disability ...
Status
Completed
Location
María José Díaz Arribas
Start Date
2017-01
Trial ID
NCT02850055
Treatments Being Tested
This longitudinal pre-post study evaluates the effects of a 12-week communi...
Status
Completed
Location
Carmen García Gomariz
Start Date
2024-01-12
Trial ID
NCT07693985
Treatments Being Tested
The goal of this clinical trial is to learn if a virtually monitored, home-...
Status
Not Yet Recruiting
Location
St. Joseph's Healthcare Hamilton
Start Date
2026-06-01
Trial ID
NCT07590141
Treatments Being Tested
A multicentre, open, randomized phase II study comparing a multimodal inter...
Status
Completed
Location
Oslo University Hospital Ullevål
Start Date
2011-10
Trial ID
NCT01419145
Treatments Being Tested
Using a comprehensive prospective clinical study design, the investigators ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02459639
SARS-CoV-2 is the coronavirus responsible for developing the disease known ...
Status
Completed
Location
IIS Aragón
Start Date
2022-09-26
Trial ID
NCT06063031
This is an open-label, randomized, comparative, multicenter, 48-week study ...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT00202839